Eurofins BioPharma Product Testing North America

Do you have full visibility across your biosafety testing strategy? Each stage, from cell bank testing to stability, plays a critical role in ensuring product safety and regulatory success.

Undetected viral contaminants can derail development and risk patient safety. Modern biologics demand more sensitive and comprehensive testing methods. Learn how NGS overcomes the limitations of traditional assays.

Are your viral clearance studies built to meet today’s regulatory expectations? From model virus selection to data robustness, every decision matters. Learn how to design studies that stand up to scrutiny and protect patient safety.

What does a successful partnership with a qualified rapid microbiology testing provider look like? Partnerships with strong collaboration are critical, especially when navigating patient health, compliance, and other challenges that may arise. Take a look at our On-Demand Webinar to learn more.

How confident are you in your sterile fill-finish operations? Preserving high-value drug product can be a challenge for many biopharmaceutical manufacturers. Discover the best approaches and strategies to protect valuable clinical material, streamline operations, and ensure regulatory compliance. Watch our webinar to learn more.

Endonuclease (Serratia marcescens) plays a key role in removing host cell nucleic acids, yet qualification practices often differ across programs. With new expectations shaping how ancillary materials are assessed, clear activity methods matter. This session walks through USP’s proposed General Chapter <89.3>, including a validated spectrophotometric assay and reference standard, and shows how these tools support consistent lot release and comparability planning. Watch the webinar to see how this method works and what it means for your workflow.